Follow
James Halpert
James Halpert
Verified email at arizona.edu
Title
Cited by
Cited by
Year
Ethoxy-, pentoxy-and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450
MD Burke, S Thompson, CR Elcombe, J Halpert, T Haaparanta, RT Mayer
Biochemical pharmacology 34 (18), 3337-3345, 1985
16071985
The genetic determinants of the CYP3A5 polymorphism
E Hustert, M Haberl, O Burk, R Wolbold, YQ He, K Klein, AC Nuessler, ...
Pharmacogenetics and Genomics 11 (9), 773-779, 2001
8302001
An open conformation of mammalian cytochrome P450 2B4 at 1.6-Å resolution
EE Scott, YA He, MR Wester, MA White, CC Chin, JR Halpert, EF Johnson, ...
Proceedings of the National Academy of Sciences 100 (23), 13196-13201, 2003
4422003
Structure of mammalian cytochrome P450 2B4 complexed with 4-(4-chlorophenyl) imidazole at 1.9-Å resolution: insight into the range of P450 conformations and the coordination of …
EE Scott, MA White, YA He, EF Johnson, CD Stout, JR Halpert
Journal of Biological Chemistry 279 (26), 27294-27301, 2004
3552004
Identification and functional characterization of eight CYP3A4 protein variants
R Eiselt, TL Domanski, A Zibat, R Mueller, E Presecan-Siedel, E Hustert, ...
Pharmacogenetics and Genomics 11 (5), 447-458, 2001
3392001
Analysis of human cytochrome P450 3A4 cooperativity: construction and characterization of a site-directed mutant that displays hyperbolic steroid hydroxylation kinetics
GR Harlow, JR Halpert
Proceedings of the National Academy of Sciences 95 (12), 6636-6641, 1998
2971998
Selective inhibitors of cytochromes P450
JR Halpert, FP Guengerich, JR Bend, MA Correia
Toxicology and applied pharmacology 125 (2), 163-175, 1994
2881994
cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450
TL Domanski, C Finta, JR Halpert, PG Zaphiropoulos
Molecular Pharmacology 59 (2), 386-392, 2001
2872001
Toxicology of thiono-sulfur compounds
RA Neal, J Halpert
Annual review of pharmacology and toxicology 22 (1), 321-339, 1982
2251982
Amino acid sequence of a presynaptic neurotoxin from the venom of Notechis scutatus scutatus (Australian tiger snake).
J Halpert, D Eaker
Journal of Biological Chemistry 250 (17), 6990-6997, 1975
2211975
Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: an evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivation
KK Khan, YQ He, TL Domanski, JR Halpert
Molecular pharmacology 61 (3), 495-506, 2002
2082002
Alanine-scanning mutagenesis of a putative substrate recognition site in human cytochrome P450 3A4: role of residues 210 and 211 in flavonoid activation and substrate specificity
GR Harlow, JR Halpert
Journal of Biological Chemistry 272 (9), 5396-5402, 1997
1891997
Structure of microsomal cytochrome P450 2B4 complexed with the antifungal drug bifonazole: insight into P450 conformational plasticity and membrane interaction
Y Zhao, MA White, BK Muralidhara, L Sun, JR Halpert, CD Stout
Journal of biological chemistry 281 (9), 5973-5981, 2006
1882006
Analysis of mammalian cytochrome P450 structure and function by site-directed mutagenesis
TL Domanski, JR Halpert
Current drug metabolism 2 (2), 117-137, 2001
1762001
Molecular modeling of cytochrome P450 3A4
GD Szklarz, JR Halpert
Journal of computer-aided molecular design 11, 265-272, 1997
1731997
Phenylalanine and tryptophan scanning mutagenesis of CYP3A4 substrate recognition site residues and effect on substrate oxidation and cooperativity
TL Domanski, YA He, KK Khan, F Roussel, Q Wang, JR Halpert
Biochemistry 40 (34), 10150-10160, 2001
1722001
Analysis of four residues within substrate recognition site 4 of human cytochrome P450 3A4: role in steroid hydroxylase activity and α-naphthoflavone stimulation
TL Domanski, J Liu, GR Harlow, JR Halpert
Archives of biochemistry and biophysics 350 (2), 223-232, 1998
1641998
The role of phospholipase activity in the action of a presynaptic neurotoxin from the venom of Notechis scutatus scutatus (Australian tiger snake)
J Halpert, D Eaker, E Karlsson
Febs Letters 61 (1), 72-76, 1976
1611976
Structural basis of selective cytochrome P450 inhibition
JR Halpert
Annual Review of Pharmacology and Toxicology 35 (1), 29-53, 1995
1561995
A truncation of 2B subfamily cytochromes P450 yields increased expression levels, increased solubility, and decreased aggregation while retaining function
EE Scott, M Spatzenegger, JR Halpert
Archives of Biochemistry and Biophysics 395 (1), 57-68, 2001
1532001
The system can't perform the operation now. Try again later.
Articles 1–20